Amgen and Horizon files counterclaim against US trade regulators
Amgen and Horizon have filed a counterclaims against a lawsuit filed by the Federal Trade Commission (FTC). The companies claim that the FTC’s lawsuit to stop the USD 28bn merger between the two ”completely ignores” the provisions of the US Constitution, reports independent media Endpoints News.
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
Get full access for you and your coworkers
Start a free company trial todayRelated articles
Amgen "disappointed" by resistance to Horizon acquisition
For subscribers